On Call Chosen Blood Glucose Monitoring System
Glucose Oxidase, Glucose. 510(k) K111371, from ACON Laboratories, Inc. (San Diego, CA). Product code CGA, class 2.
As of Nov 20, 2026, K111371 is an FDA 510(k) held by ACON Laboratories, Inc., substantially equivalent on Oct 6, 2011 after 143 days, with no recalls tied to it in FDA's recall database.
- Review time: 143 days
- Recalls: 0
The On Call ® Chosen Blood Glucose Monitoring System is an electrochemical enzymatic assay for the quantitative detection of glucose in fresh capillary whole blood from the fingertip by people with diabetes at home as an aid in monitoring the effectiveness of diabetes control programs. Alternate (forearm and palm) testing sites should be used only when blood glucose level is not changing rapidly.
- One Touch Ultra Blood Glucose Monitoring SystemK002134 · Selfcare, Inc. · Aug 7, 2000
- ABL90 FLEX PLUS SystemK252488 · Radiometer Medicals Aps · May 1, 2026
- YSI 2900C Biochemistry AnalyzerK210933 · Ysi, Inc. · Sep 30, 2024
- EasyStat 300K220328 · Medica Corporation · Jul 26, 2024
- i-STAT G cartridge with the i-STAT 1 SystemK223755 · Abbott Point of Care, Inc. · Sep 11, 2023
- i-STAT CG8+ cartridge with the i-STAT 1 SystemK223710 · Abbott Point of Care, Inc. · Jul 28, 2023
- GEM Premier ChemSTATK223090 · Instrumentation Laboratory CO · Jan 27, 2023
- Nova Primary Glucose Analyzer SystemK203549 · Nova Biomedical Corporation · Oct 18, 2022
- i-STAT CHEM8+ cartridge with the i-STAT 1 SystemK210958 · Abbott Point of Care, Inc. · Aug 13, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 16, 2011
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files